["{\n\"step_by_step_thinking\": \"The question is about adjuvant aromatase inhibitors, but the provided documents do not mention this specific treatment. Instead, they discuss tamoxifen as an antiestrogen and its use in breast cancer treatment. There are no references to aromatase inhibitors or cardiovascular risk in postmenopausal women with early breast cancer. Therefore, we cannot determine whether adjuvant aromatase inhibitors increase the cardiovascular risk.\",\n\"answer_choice\": \"C\"\n}"]